Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
02 2022
Historique:
received: 14 03 2021
accepted: 29 11 2021
pubmed: 15 1 2022
medline: 25 2 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

The OAS1/2/3 cluster has been identified as a risk locus for severe COVID-19 among individuals of European ancestry, with a protective haplotype of approximately 75 kilobases (kb) derived from Neanderthals in the chromosomal region 12q24.13. This haplotype contains a splice variant of OAS1, which occurs in people of African ancestry independently of gene flow from Neanderthals. Using trans-ancestry fine-mapping approaches in 20,779 hospitalized cases, we demonstrate that this splice variant is likely to be the SNP responsible for the association at this locus, thus strongly implicating OAS1 as an effector gene influencing COVID-19 severity.

Identifiants

pubmed: 35027740
doi: 10.1038/s41588-021-00996-8
pii: 10.1038/s41588-021-00996-8
pmc: PMC8837537
doi:

Substances chimiques

2',5'-Oligoadenylate Synthetase EC 2.7.7.84

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-127

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM008638
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : UL1TR001878
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/D/10002070
Organisme : NIDDK NIH HHS
ID : K25 DK128563
Pays : United States
Organisme : Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre)
ID : 409511
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : K25DK128563
Organisme : Medical Research Council
ID : MC_PC_19025
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : UL1 TR001873
Pays : United States
Organisme : Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre)
ID : 365825
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : UL1TR001873
Organisme : Medical Research Council
ID : MC_PC_19059
Pays : United Kingdom
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BBS/E/D/30002275

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2022. The Author(s).

Références

COVID-19 Host Genetics InitiativeThe COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.Eur. J. Hum. Genet. 28, 715–718 (2020).
doi: 10.1038/s41431-020-0636-6
Ellinghaus, D. et al. Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med. 383, 1522–1534 (2020).
doi: 10.1056/NEJMoa2020283
Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in COVID-19. Nature 591, 92–98 (2021).
doi: 10.1038/s41586-020-03065-y
Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.Science 370, eabd4570 (2020).
doi: 10.1126/science.abd4570
COVID-19 Host Genetics Initiative Mapping the human genetic architecture of COVID-19. Nature https://doi.org/10.1038/s41586-021-03767-x (2021).
Zeberg, H. & Pääbo, S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature 587, 610–612 (2020).
doi: 10.1038/s41586-020-2818-3
Zeberg, H. & Pääbo, S. A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Proc. Natl Acad. Sci. USA 118, e2026309118 (2021).
doi: 10.1073/pnas.2026309118
Choi, U. Y., Kang, J.-S., Hwang, Y. S. & Kim, Y.-J. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 47, e144 (2015).
doi: 10.1038/emm.2014.110
Zhou, S. et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat. Med. 27, 659–667 (2021).
doi: 10.1038/s41591-021-01281-1
Bonnevie-Nielsen, V. et al. Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.Am. J. Hum. Genet. 76, 623–633 (2005).
doi: 10.1086/429391
Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Rentzsch, P., Schubach, M., Shendure, J. & Kircher, M. CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 13, 31 (2021).
doi: 10.1186/s13073-021-00835-9
Green, R. E. et al. A draft sequence of the Neandertal genome. Science 328, 710–722 (2010).
doi: 10.1126/science.1188021
Chen, L., Wolf, A. B., Fu, W., Li, L. & Akey, J. M. Identifying and interpreting apparent Neanderthal ancestry in African individuals. Cell 180, 677–687.e16 (2020).
doi: 10.1016/j.cell.2020.01.012
Sankararaman, S., Patterson, N., Li, H., Pääbo, S. & Reich, D. The date of interbreeding between Neandertals and modern humans. PLoS Genet. 8, e1002947 (2012).
doi: 10.1371/journal.pgen.1002947
Wickenhagen, A. et al. A prenylated dsRNA sensor protects against severe COVID-19.Science 374, eabj3624 (2021).
doi: 10.1126/science.abj3624
Sams, A. J. et al. Adaptively introgressed Neandertal haplotype at the OAS locus functionally impacts innate immune responses in humans. Genome Biol. 17, 246 (2016).
doi: 10.1186/s13059-016-1098-6
Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557 (2015).
doi: 10.1093/bioinformatics/btv402
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
doi: 10.1093/bioinformatics/btw018
Gaziano, J. M. et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214–223 (2016).
doi: 10.1016/j.jclinepi.2015.09.016
Hunter-Zinck, H. et al. Genotyping array design and data quality control in the Million Veteran Program. Am. J. Hum. Genet. 106, 535–548 (2020).
doi: 10.1016/j.ajhg.2020.03.004
Chapman, A. et al. A natural language processing system for national COVID-19 surveillance in the US Department of Veterans Affairs. In Proc. 1st Workshop on NLP for COVID-19 at ACL 2020 (Association for Computational Linguistics, 2020).
Fang, H. et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies. Am. J. Hum. Genet. 105, 763–772 (2019).
doi: 10.1016/j.ajhg.2019.08.012
Kowalski, M. H. et al. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations. PLoS Genet. 15, e1008500 (2019).
doi: 10.1371/journal.pgen.1008500
Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
doi: 10.1371/journal.pgen.0020190
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
doi: 10.1038/ng1847
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021).
doi: 10.1038/s41588-021-00870-7
Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335–1341 (2018).
doi: 10.1038/s41588-018-0184-y
Kosmicki, J. A. et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am. J. Hum. Genet. 108, 1350–1355 (2021).
doi: 10.1016/j.ajhg.2021.05.017

Auteurs

Jennifer E Huffman (JE)

Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.

Guillaume Butler-Laporte (G)

Departments of Medicine, Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.

Atlas Khan (A)

Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Erola Pairo-Castineira (E)

Roslin Institute, University of Edinburgh, Edinburgh, UK.
Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Theodore G Drivas (TG)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania,, Philadelphia, PA, USA.
Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Gina M Peloso (GM)

Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA, USA.
Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Tomoko Nakanishi (T)

Department of Human Genetics, McGill University, Montréal, Québec, Canada.
Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Japan Society for the Promotion of Science, Tokyo, Japan.

Andrea Ganna (A)

Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Anurag Verma (A)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania,, Philadelphia, PA, USA.
Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Corporal Michael Crescenz VA Medical Center, Philadelphia, PA, USA.

J Kenneth Baillie (JK)

Roslin Institute, University of Edinburgh, Edinburgh, UK.
Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK.

Krzysztof Kiryluk (K)

Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Institute for Genomic Medicine, Columbia University, New York, NY, USA.

J Brent Richards (JB)

Departments of Medicine, Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.
Department of Twin Research, King's College London, London, UK.

Hugo Zeberg (H)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany. hugo.zeberg@ki.se.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. hugo.zeberg@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH